Are you Dr. Chan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 91 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3601 21st Ave S
Nashville, TN 37232Phone+1 615-322-3000
Summary
- Dr. Emily Chan, MD is an oncologist in Nashville, Tennessee. She is currently licensed to practice medicine in Tennessee. She is affiliated with Vanderbilt University Medical Center and Tennessee Valley HCS - Nashville and Murfreesboro.
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2001 - 2005
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1998 - 2001
- Weill Cornell MedicineClass of 1998
Certifications & Licensure
- TN State Medical License 2005 - 2025
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of Vitamin D in Untreated Metastatic Colorectal Cancer Start of enrollment: 2012 Apr 13
- Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting Start of enrollment: 2014 Feb 05
- A Study of DKN-01 in Combination With Paclitaxel or Pembrolizumab Start of enrollment: 2014 May 05
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsDifferential Immunohistochemical and Molecular Profiling of Conventional and Aggressive Components of Chromophobe Renal Cell Carcinoma: Pitfalls for Diagnosis.Constance V. Chen, Nicole A. Croom, Jeffry P. Simko, Bradley A. Stohr, Emily Chan
Human Pathology. 2021-11-17 - 8 citationsPapillary Renal Cell Carcinoma With Microcystic Architecture Is Strongly Associated With Extrarenal Invasion and Metastatic DiseaseEmily Chan, Bradley A. Stohr, Robert S. Butler, Roni M. Cox, Jonathan Myles
The American Journal of Surgical Pathology. 2021-09-09 - 21 citationsTERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor.Ivan de Kouchkovsky, Li Zhang, Errol J. Philip, Francis Wright, Daniel M Kim
Journal for Immunotherapy of Cancer. 2021-05-01
Press Mentions
- Completion of Adjuvant Chemotherapy After Pancreatic Resection Linked with Improved SurvivalJanuary 18th, 2014
Professional Memberships
- Member